Pseudomyxoma peritonei laboratory findings

Pseudomyxoma peritonei Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Pseudomyxoma peritonei from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudomyxoma peritonei laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudomyxoma peritonei laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudomyxoma peritonei laboratory findings
CDC on Pseudomyxoma peritonei laboratory findings
Pseudomyxoma peritonei laboratory findings in the news
Blogs on Pseudomyxoma peritonei laboratory findings
Directions to Hospitals Treating Pseudomyxoma peritonei
Risk calculators and risk factors for Pseudomyxoma peritonei laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Laboratory Findings

The laboratory findings associated with pseudomyxoma peritonei are:

• Carcinoembryonic antigen (CEA)

• Carbohydrate antigen 19.9 (CA19.9)

• Carbohydrate antigen 125 (CA125)

These tumor markers are also used as a baseline value for postoperative follow-up. Moreover, they have been reported as predictors of the completeness of cytoreductive surgery, a significant prognostic factor for PMP.

References

Template:WikiDoc Sources